Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand

How to cite this article:
Yasri S, Wiwanitkit V. Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand. Ann Trop Med Public Health 2015;8:71-2

 

How to cite this URL:
Yasri S, Wiwanitkit V. Neuraminidase inhibitor resistance of the isolated influenza virus: Analysis of 54-month data from Thailand. Ann Trop Med Public Health [serial online] 2015 [cited 2020 Aug 6];8:71-2. Available from: https://www.atmph.org/text.asp?2015/8/3/71/157636

Dear Sir,

At present, acute febrile illness due to influenza virus infection has become a public concern. The infection can be seen worldwide and is the focus of disease surveillance and control by the World Health Organization (WHO). An interesting issue of the influenza virus study, at present, is the emergence of the drug resistance strain. The drug-resistant influenza can be problematic and difficult to treat. [1] The monitoring of drug resistance is an interesting aspect of laboratory study. However, due to its high cost, it is not routinely done in the developing countries. Here, the authors have tried to analyze the primary data in the official report from the Thai National Influenza Center, Thailand. [2] The data on the neuraminidase inhibitor resistance test of the isolated influenza virus within the period between January 2009 and May 2013 were collected. Interestingly, within the studied period of 53 months, there were 1,600 studied isolations and 0.68% were neuraminidase inhibitor resistant. Classified by subgroup, the resistance can be seen in 0%, 0%, 1.36%, and 99.55% of influenza B, influenza A virus subtype H3N2 (H3N2), the new emerging influenza A (H1N1), and the classical H1N1, respectively. It can be seen that the resistance was in only the H1N1s. In this report, the rate is higher than the one observed at a single center in Thailand (about 0.31%). [3] This shows the fact that the presently used neuraminidase inhibitor will be little useful for fighting H1N1 influenza in Thailand.

References

 

1.
Hurt AC. The epidemiology and spread of drug resistant human influenza viruses. Curr Opin Virol 2014;8:22-9.
2.
Thai Department of Medical Science. News Letter. Dept Med Sci Lett 2013;27:5.
3.
Payungporn S, Poomipak W, Makkoch J, Rianthavorn P, Theamboonlers A, Poovorawan Y. Detection of oseltamivir sensitive/resistant strains of pandemic influenza A virus (H1N1) from patients admitted to hospitals in Thailand. J Virol Methods 2011;177:133-9.

Source of Support: None, Conflict of Interest: None

Check

DOI: 10.4103/1755-6783.157636

Paul Mies has now been involved with test reports and comparing products for a decade. He is a highly sought-after specialist in these areas as well as in general health and nutrition advice. With this expertise and the team behind atmph.org, they test, compare and report on all sought-after products on the Internet around the topics of health, slimming, beauty and more. The results are ultimately summarized and disclosed to readers.

LEAVE A REPLY

Please enter your comment!
Please enter your name here